Journal of the American Heart Association

FEBRUARY 29, 2024

The objective of this study was to examine the prospective association between plasma RvD2 and the risk of atherosclerotic cardiovascular disease (ASCVD) at the population level.Methods and ResultsA cohort of 2633 community‐dwelling individuals aged 35–60 years was followed for 8 years in this study. P<0.001).

Cholesterol 63

Cholesterol Cardiovascular Disease Atherosclerosis Outcomes 63

American College of Cardiology

MAY 22, 2024

Reduction in low-density lipoprotein cholesterol (LDL-C) levels has consistently demonstrated a reduced risk of atherosclerotic cardiovascular disease (ASCVD). There is extensive evidence from randomized trials that demonstrates the effectiveness of lipid-lowering agents in reducing ASCVD-related events.

Cholesterol 75

Cholesterol Dementia Hemorrhage Cardiovascular Disease 75

Medical Xpress - Cardiology

DECEMBER 13, 2023

A recent trial of a novel gene-editing technique that lowered dangerously high cholesterol by up to 55% has generated talk of a new front opening against cardiovascular disease, which kills nearly 700,000 Americans each year and is the nation's leading cause of death.

Cholesterol 75

Cholesterol Cardiovascular Disease 75

DAIC

APRIL 24, 2024

The app also recorded other significant heart health risk factors, such as cholesterol, weight, and physical activity via integration with external sources including electronic medical records and fitness trackers. Change in blood pressure (BP), LDL cholesterol, and weight were evaluated from baseline to follow up.

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart Attack 116

DAIC

FEBRUARY 1, 2024

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Peripheral Arterial Disease Stroke 104

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

AimsHistorically, atherosclerotic cardiovascular disease (ASCVD) risk profile mitigation has had a predominant focus on low density lipoprotein cholesterol (LDL-C). This relationship is complicated by the co-existence of low high-density lipoprotein cholesterol.

Cardiovascular Disease 52

Cardiovascular Disease Pharmacology Cholesterol Risk Factors 52

Journal of the American Heart Association

MARCH 8, 2024

Lowering low‐density lipoprotein cholesterol (LDL‐C) is a cornerstone of reducing risk for atherosclerotic cardiovascular disease. Journal of the American Heart Association, Ahead of Print. Barriers include poor adherence, clinical inertia, concern for side effects, cost, and complex prior authorization processes.

Cholesterol 79

Cholesterol Cardiovascular Disease Article Circulation 79

Cardiology Update

JANUARY 24, 2024

The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Med Page Today

AUGUST 31, 2024

(MedPage Today) -- LONDON -- A combination of three factors -- high-sensitivity C-reactive protein (hsCRP), LDL cholesterol, and lipoprotein(a), or lp(a) -- independently predicted cardiovascular disease over 30 years in women who were initially.

Cholesterol 94

Cholesterol Cardiovascular Disease 94

Cardiovascular Diabetology

JANUARY 8, 2024

Remnant cholesterol (RC) is implicated in the risk of cardiovascular disease. However, comprehensive population-based studies elucidating its association with aortic valve calcium (AVC) progression are limited.

Aortic valve 52

Aortic valve Cholesterol Aortic Cardiovascular Disease 52

Circulation

NOVEMBER 29, 2023

BACKGROUND:Cholesterol efflux capacity (CEC) predicts cardiovascular disease independently of high-density lipoprotein (HDL) cholesterol levels. Enhanced CEC, as seen with the smaller particles, predicts decreased cardiovascular disease risk. Circulation, Ahead of Print.

Cholesterol 75

Cholesterol Cardiovascular Disease Physiology Circulation 75

DAIC

MAY 21, 2024

A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. statins). .

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Science Daily - Heart Disease

NOVEMBER 13, 2023

Researchers have discovered the mechanism by which cholesterol in our diet is absorbed into our cells. This discovery opens up new opportunities for therapeutic intervention to control cholesterol uptake that could complement other therapies and potentially save lives.

Cardiovascular Disease 87

Cardiovascular Disease Cholesterol Diet Stroke 87

HCPLive

MAY 1, 2024

Erin Michos, MD, delivers a comprehensive review of lipid management and its influence on cardiovascular disease, emphasizing recent studies that underscore the need for improved treatment strategies for high-risk patients.

Cholesterol 52

Cholesterol Cardiovascular Disease 52

Medical Xpress - Cardiology

JULY 3, 2024

Many patients receive a standardized lipid panel as part of a yearly physical that includes testing of their "good" cholesterol (high-density lipoprotein) and "bad" cholesterol (low-density lipoprotein). However, most people are unfamiliar with another type of cholesterol, lipoprotein(a) or Lp(a).

Cholesterol 81

Cholesterol Risk Factors Cardiovascular Disease 81

Medical Xpress - Cardiology

JULY 29, 2024

A recently unveiled cardiovascular disease risk calculator that measures a patient's risk for heart attack and stroke is better calibrated and more precise than its previous version, but if current treatment guidelines for cholesterol and blood pressure therapy remain unchanged, the new calculator may have unintended consequences, according to research (..)

Heart Attack 98

Heart Attack Heart attacks Blood Pressure Stroke 98

Journal of Clinical Investigation - Cardiology

MARCH 1, 2024

Patients with chronic inflammatory disorders such as psoriasis have an increased risk of cardiovascular disease and elevated levels of LL37, a cathelicidin host defense peptide that has both antimicrobial and proinflammatory properties.

Atherosclerosis 117

Atherosclerosis Cholesterol Cardiovascular Disease Plaque 117

Science Daily - Heart Disease

FEBRUARY 20, 2024

But a new study suggests the drug may also provide a surprising and life-saving benefit: lowering cholesterol and cutting the overall risk of cardiovascular disease. The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide.

Heart Disease 120

Heart Disease Cholesterol Cardiovascular Disease 120

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundAortic stenosis has pathophysiological similarities with atherosclerosis, including the deposition of cholesterol‐containing lipoproteins. The resulting cholesterol crystals activate the NLRP3 (NOD‐like receptor protein 3) inflammasome, leading to inflammation and cardiovascular diseases. mg/dL versus 97.9±37.6

Aortic valve 40

Aortic valve Cholesterol Aortic Stenosis 40

Med Page Today

APRIL 12, 2024

(MedPage Today) -- Patients with persistent non-high-density lipoprotein (HDL) cholesterol dyslipidemia from childhood to adulthood had an increased risk of cardiovascular disease (CVD) events, but those who had resolved this by adulthood had a.

Cholesterol 98

Cholesterol Cardiovascular Disease 98

The American Journal of Cardiology

JANUARY 23, 2024

Publication date: Available online 23 January 2024 Source: The American Journal of Cardiology Author(s): Shichiro Abe, Setus Nishino, Tomoaki Kanaya, Masashi Sakuma, Shigeru Toyoda

Cardiovascular Disease 40

Cardiovascular Disease Cholesterol 40

Medical Xpress - Cardiology

FEBRUARY 23, 2024

When people hear about predicting heart disease, most will think of cholesterol levels.

Cholesterol 105

Cholesterol Biomarkers Heart Disease Cardiovascular Disease 105

American College of Cardiology

MAY 20, 2024

Does apolipoprotein B (apoB) have a utility in atherosclerotic cardiovascular disease (ASCVD) or are low-density lipoprotein cholesterol (LDL-C), non–high-density lipoprotein cholesterol (non–HDL-C), and triglycerides sufficient for routine cardiovascular (CV) care?

Cholesterol 61

Cholesterol Cardiovascular Disease Article 61

JAMA Cardiology

JANUARY 16, 2024

This prespecified analysis of the Cholesterol Lowering via Bempedoic Acid, an ATP Citrate Lyase (ACL)–Inhibiting Regimen (CLEAR) Outcomes trial investigates if bempedoic acid is associated with a reduction in the total burden of cardiovascular events in patients at high risk for cardiovascular disease.

Cholesterol 99

Cholesterol Cardiovascular Disease Outcomes 99

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL). The median duration of follow-up was 10 years (IQR 3–16). 3.17, P  = 0.006).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Coronary Artery Disease 45

Science Daily - Heart Disease

FEBRUARY 19, 2024

Researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol. The team discovered a link between 4PY, a breakdown product from excess niacin, and heart disease.

Heart Disease 110

Heart Disease Heart Attack Heart attacks Atherosclerosis 110

All About Cardiovascular System and Disorders

APRIL 30, 2024

Exercise in a regular pattern is one of the important life style modifications which everyone can adopt to prevent or delay cardiovascular disease. Exercise helps in various ways for prevention of cardiovascular disease. High density lipoprotein cholesterol in the blood increases with regular exercise.

Exercise 52

Exercise Heart Disease Blood Pressure Cholesterol 52

HCPLive

MARCH 25, 2024

This clinical quiz will test your knowledge on the use of non-statin therapies for LDL-C lowering based on the American College of Cardiology's 2022 Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk.

Cholesterol 72

Cholesterol Cardiovascular Disease 72

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Introduction Statins remain the first-line treatment for secondary prevention of cardiovascular (CV) events, with lowering of low-density lipoprotein cholesterol (LDL-C) being their therapeutic target.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

JUNE 24, 2024

Dyslipidaemia is a complex disorder characterised by abnormal lipid levels in the blood, including cholesterol and triglycerides, and plays an important role in the development of atherosclerotic cardiovascular disease. Most risk factors for cardiovascular disease are modifiable, and dyslipidaemia is a key factor among them.

Cholesterol 52

Cholesterol Cardiovascular Disease Risk Factors 52

HCPLive

MAY 1, 2024

Key opinion leaders in cardiology share insights on reducing LDL cholesterol to manage cardiovascular disease risk, educating patients not reaching goals, and implementing real-world clinical strategies for maintaining lower LDL levels.

Cholesterol 52

Cholesterol Education Cardiovascular Disease 52

Cardiometabolic Health Congress

AUGUST 23, 2024

Newly included risk factors— untreated vision loss and high LDL cholesterol —underscore the critical role of these elements in maintaining cognitive health. The Cholesterol Connection Cholesterol’s recognition as a risk factor for dementia marks a pivotal advancement in understanding, preventing, and delaying cognitive decline.

Dementia 52

Dementia Cholesterol Risk Factors CME 52

The New England Journal of Medicine

APRIL 5, 2024

The identification of an inverse association between high-density lipoprotein (HDL) cholesterol levels and incident cardiovascular disease events,1 combined with research on the role of HDL in reverse cholesterol transport, led to the exploration of therapies directed toward increasing HDL cholesterol.

Cholesterol 40

Cholesterol Cardiovascular Disease Research 40

DAIC

MARCH 13, 2024

Zerlasiran is a siRNA (short interfering RNA) designed to lower the body’s production of Lp(a), a key genetic risk factor for cardiovascular disease affecting up to 20% of the world’s population.

Cardiovascular Disease 98

Cardiovascular Disease Risk Factors Cholesterol Heart Attack 98

Frontiers in Cardiovascular Medicine

JULY 31, 2024

Recent clinical trials demonstrated that proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors reduce cardiovascular events without affecting systemic inflammation in the patients with coronary artery disease, as determined by high sensitivity C-reactive protein (CRP) levels.

Coronary Artery Disease 52

Coronary Artery Disease Cholesterol Cardiovascular Disease 52

The British Journal of Cardiology

AUGUST 1, 2024

Raised lipoprotein(a) (Lp[a]) cholesterol is highly prevalent affecting 1 in 5 individuals and is also frequently associated with the inherited condition familial hypercholesterolaemia (FH).

Peripheral Arterial Disease 52

Peripheral Arterial Disease Risk Factors Cholesterol Cardiovascular Disease 52